The Centers for Medicare & Medicaid Services has directed private insurers providing Medicare Advantage plans to cover Biogen ...
Corcept Therapeutics said on Wednesday its experimental drug failed to meet the main goal of a mid-stage trial in patients ...
It's a gray morning at Grapevine Lake, but people are showing up to run laps around the marina. That includes Troy Pruett.
Shelby Kinsey lives with a rare, fast-progressing form of ALS — but she has to spend her precious time fighting for insurance ...
Troy Pruett, a Grapevine resident, will be competing in his 96th marathon this weekend and getting one step closer to the ...
In a rare move, the U.S. agency behind Medicare is warning Medicare Advantage providers they can’t have blanket policies that ...
Corcept Therapeutics’ selective cortisol modulator failed to slow the progress of amyotrophic lateral sclerosis (ALS) in a ...
CMS has reportedly directed Medicare Advantage plan providers to cover Biogen's drug Qalsody for ALS following reports it was ...
Exeter Hospital announced in the fall that it plans to terminate its ALS service. Here's how Seacoast fire departments are ...